5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Arvee Laboratories (India) Ltd.

•
arveelabs.comBSE: -NSE: ARVEE
Market Cap₹ 183 Cr.
Current Price
High / Low₹ 291 / 129
Stock P/E45.1
Book Value₹ 32
Price to Book5.01
Dividend Yield0.00 %
ROCE10.0 %
ROE7.1 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence
55%
View full sector analysis →

PROS

  • Company is almost debt free
  • Stock looks reasonably valued - P/E of 45.1 is below its historical median
  • Company comfortably covers its interest (12.6x coverage)
  • Company generates healthy free cash flow

CONS

  • Operating cash flow has been negative in recent years
  • Company has a low return on equity of 8.9% over last 3 years
  • Company's sales have been declining over the last five years
  • Company has delivered a poor profit growth of -1.4% over past five years
  • Operating margins have contracted to 9.4% from 15.2%
  • Stock is trading at 5.0x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsChemicals
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SOLARINDS20550.0093.38185957.060.05666.3788.983668.2070.2638.1627.91
2.PIDILITIND1636.4062.88166565.831.318835.101202.8645515.501112.7432.3826.28
3.SRF2597.0035.6176981.530.35758.8775.535033.2634.6314.2124.57
4.FLUOROCHEM4731.2584.5151972.780.06219.0019.021588.0023.979.5826.83
5.NAVINFLUOR8538.2555.4743808.150.18243.31107.671045.0844.0721.3934.17
6.GODREJIND1138.5532.6238352.180.00523.36-27.855448.0922.1610.6412.82
7.DEEPAKNTR1733.6530.1923645.780.43345.01207.362577.6036.3911.5820.96
8.AETHER1646.0592.8921847.670.0062.7533.45326.5627.4911.6531.47
9.ATUL6484.4024.0019091.210.46253.9391.851847.9525.0315.0521.41
10.AARTIIND505.4534.5318334.020.20155.00260.472387.0042.426.9516.00
11.DEEPAKFERT1417.1018.2417949.400.71490.04100.953256.2622.4712.1225.96
12.ARVEE165.8145.14182.720.001.69896.4717.23130.2810.0014.49
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
898611139673101117
7875911967381015
Operating Profit1111220000212
OPM %12.89%7.74%6.88%12.87%14.53%11.97%3.93%3.41%4.41%3.48%16.56%10.09%14.49%
Other Income0000000000000
Interest0000000000000
Depreciation0000000000000
1001110000112
Tax %24.62%25.00%25.00%79.31%25.40%25.19%23.81%33.33%5.88%0.00%-31.65%38.82%25.99%
Net Profit0000110000212
0000110000200
Equity Capital11111111111111111111111111
Reserves18181818192020202020232324
Promoter Pledge %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
2734485545474061303841
2229414939413554273536
Operating Profit5677676944—
OPM %19191512141415141211—
Other Income01000111111
Interest33321100000
Depreciation12222222111
11233436235
Tax %65-80431126262533432511
Net Profit02122334124
EPS0000032412—
Dividend Payout %0000000000—
Minority Interest00000000000
Share of Associates00000000000
Adjusted EPS0212222412—

COMPOUNDED SALES GROWTH

10 Years:
11%
5 Years:
-3%
3 Years:
-2%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
-1%
3 Years:
-6%

STOCK PRICE CAGR

10 Years:
—
5 Years:
12%
3 Years:
16%
1 Year:
2%

RETURN ON EQUITY

10 Years:
15%
5 Years:
10%
3 Years:
9%
Last Year:
7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2020

Oct 13

1:1

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
LIABILITIES----------
Equity Capital446661111111111
-10911131013171820
6778282000
Trade Payables66126101010873
2018117323333
Total Liabilities35364437344139393938
ASSETS----------
13171513131414131315
Capital Work in Progress4012211231
0002320000
7685676565
0000000068
Cash & Bank1124175125
9121812810141994
Total Assets35364437344139393938
Total Debt25251613493111
Net Working Capital34655710131016
Contingent Liabilities0000000000
Book Value per Share6.5210.3625.3229.5333.8219.3921.7225.4626.4228.37
Face Value10.0010.0010.0010.0010.0010.0010.0010.0010.0010.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
6469102434-0
Cash from Investing-5-1-1-3-3-10-1-2-1
Cash from Financing-1-3-4-5-105-6-2-0-0
0-012-36-2-11-2
Free Cash Flow23588-0211-2
OCF / Net Profit33.232.605.524.184.490.641.560.713.48-0.10
Cumulative 5-Year FCF000025232219122

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
PER SHARE
EPS (₹)0.463.831.984.114.172.432.343.740.951.95
Book Value (₹)6.5210.3625.3229.5333.8219.3921.7225.4626.4228.37
Dividend per Share (₹)0.000.000.000.000.000.000.000.000.000.00
Cash EPS (₹)2.074.472.944.194.164.614.445.632.312.99
PROFITABILITY
Operating Margin %18.99%18.61%15.49%11.89%14.02%13.98%15.22%11.87%9.68%9.38%
Net Margin %0.70%4.51%2.28%4.12%5.06%5.65%6.38%6.71%3.47%5.58%
ROE %9.24%45.41%12.01%14.97%13.17%13.38%11.36%15.84%3.68%7.11%
ROCE %14.39%15.19%17.69%14.10%15.79%15.99%13.33%23.35%7.03%10.00%
0.61%4.38%2.73%5.57%6.50%7.17%6.46%10.65%2.72%5.64%
EFFICIENCY
Debtor Days527691785855917311169
Inventory Days91705542455460316652
Payable Days9799111851001211588218187
474735352-12-821-433
FINANCIAL HEALTH
Debt to Equity (x)9.59x5.96x1.16x0.79x0.21x0.42x0.13x0.04x0.03x0.03x
Interest Coverage (x)1.17x1.25x1.58x2.56x4.13x7.32x10.31x16.89x8.33x12.56x
1.24x1.26x1.28x1.29x1.43x1.40x1.75x2.44x2.38x5.14x
GROWTH
Revenue Growth %106.80%28.35%38.80%14.91%-17.27%4.31%-14.88%52.12%-50.54%26.83%
Operating Profit Growth %134.39%25.78%15.48%-11.77%-2.47%4.04%-7.32%40.61%-58.57%19.31%
Net Profit Growth %111.38%728.04%-29.81%107.77%1.60%16.46%-3.87%60.03%-74.46%104.15%
0.00%0.00%0.00%0.00%0.00%0.00%0.00%60.03%-74.46%104.15%
VALUATION
P/E (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x23.54x150.24x72.87x
P/B (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x3.46x5.43x5.01x
Dividend Yield %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
0.00x0.00x0.00x0.00x0.00x0.00x0.00x11.25x43.93x35.75x

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
73.5073.5073.5073.5073.5073.5073.5173.5073.50
FIIs0.000.000.000.000.000.000.000.000.00
DIIs0.000.000.000.000.000.000.000.000.00
Government0.000.000.000.000.000.000.000.000.00
26.5026.5026.5026.5026.5026.5026.4926.5026.50

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-07
Outcome of Board Meeting

2026-08-07 - Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-04
Corrigendum

2026-08-04 - Arvee Laboratories (India) Limited has informed the Exchange regarding Corrigendum to Other

2026-06-27
Trading Window

2026-06-27 - Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

2026-06-15
Disclosure under SEBI Takeover Regulations

2026-06-15 - Shalin Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

2026-05-19
Outcome of Board Meeting

2026-05-19 - Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

News

Recent coverage and analyst commentary for ARVEE

Loading news…

🤖

AI Stock Analyst

Arvee Laboratories (India) Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login